| 引用本文：徐爱军, 戴晨曦.我国公立医院药品价格形成机制的演变及未来政策选择[J].中国卫生政策研究,2017,10(2):1-4 |
|
| 我国公立医院药品价格形成机制的演变及未来政策选择 |
| 投稿时间：2016-11-01 修订日期：2016-12-22 PDF全文浏览 HTML全文浏览 |
| 徐爱军, 戴晨曦 |
| 南京中医药大学卫生经济管理学院 江苏南京 210046 |
| 摘要:首先分析公立医院药品采购中的销售合同及采购合同，并指出两个合同中的“市场失灵”。而政府定价、行政降价、顺加作价、集中招标采购等行政手段实施后，药品采购相关利益方采取各种博弈行为，公立医院药品采购和价格形成出现“政府失灵”。未来的公立医院药品价格形成应该为政府有限调控下的市场定价，在保持集中招标采购和零差率两个行政手段的基础上，提高医疗保险机构的价格谈判和公立医院在招标过程中的参与度。 |
| 关键词:药品价格 机制演变 政策选择 |
| 基金项目:江苏省卫生计生委2016年度人事人才管理工作科研课题（RH201602）；中国卫生经济学会课题（CHEA1617070602）；江苏省社会科学基金项目（15GLB019） |
|
| Mechanism evolution and choice of future policy for drug price formation in public hospitals in China |
| XU Ai-jun, DAI Chen-xi |
| College of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing Jiangsu 210046, China |
| Abstract:This paper firstly analyses the sales and purchase contracts in the procurement of drugs in public hospitals, and then points out the "market failure" in the two contracts. After the implementation of administrative measures such as government pricing, administrative price reduction, price increase, centralized bidding and purchasing, various drug procurement stakeholders have adopted various game behaviors, and government procurement and price formation have appeared in government hospitals, not-neglecting the formation of the price of "Government failure". The future price formation in public hospitals should be the market pricing under the limited government regulation, and increase the medical insurance institutions' price negotiation and the public hospitals' participation degree in the bidding process based on maintaining the centralized bidding and purchasing and zero administrative rate. |
| Key words:Drug price Mechanism evolution Policy choice |
| 摘要点击次数: 2155 全文下载次数: 20 |
|
|
|
|
|
